Journal article icon

Journal article

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS

Abstract:

BACKGROUND:Neoadjuvant chemotherapy (NAC) allows earlier treatment of rectal cancer micro-metastases but is not standard of care. There are currently no biomarkers predicting long-term progression-free survival (PFS) benefit from NAC. PATIENTS AND METHODS:In this single arm phase II trial, patients with non-metastatic magnetic resonance imaging (MRI)-defined operable rectal adenocarcinoma at high risk of post-operative metastatic recurrence, received 8 weeks of oxaliplatin/fluorouracil NAC th...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1038/s41416-018-0209-4

Authors


Contributors

Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Contributor
Publisher:
Springer Nature
Journal:
British Journal of Cancer More from this journal
Volume:
119
Issue:
6
Pages:
697-706
Publication date:
2019-08-17
Acceptance date:
2019-07-09
DOI:
EISSN:
1532-1827
ISSN:
0007-0920
Pmid:
30116024
Language:
English
Keywords:
Pubs id:
pubs:896725
UUID:
uuid:b1ac353b-f883-495d-a0ba-5aece3e6a079
Local pid:
pubs:896725
Source identifiers:
896725
Deposit date:
2019-06-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP